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Abstract
Inadequate preparation of prostate cancer patients undergoing radiation therapy (RT) can
damage healthy tissue and cause long-term complications. Proper setup can reduce side
effects. Currently, there are no standardized guidelines to help prepare patients for
prostate radiation. Guidelines will help nurses coordinate care and manage symptoms for
these patients. The purpose of this doctoral project was to address the gap in practice of
the lack of a standardized process for implementing presimulation interventions for
patients with prostate cancer undergoing RT by developing an evidence-based clinical
practice guideline (CPG). The practice question for this project focused on the best
practices contributing to a CPG for set up patients with prostate cancer undergoing RT
treatment. The model guiding the development of a CPG was the Johns Hopkins nursing
evidence-based practice model. Sources of evidence that informed the CPG came from
these databases: CINAHL Plus with Full Text, MEDLINE with Full Text, PubMed, Ovid
Nursing, Embase, ProQuest Nursing and Allied Health Source, and Google Scholar. The
project team used the Appraisal of Guidelines for Research and Evaluation (AGREE) II
method to assess for the validity of the CPG. A prostate radiation oncologist, RT director,
and prostate nurse analyzed the CPG using the AGREE II instrument and indicated
validity in the CPG for guiding nurses to appropriate interventions. The recommendation
is to implement a CPG with interventions that address bladder and bowel management,
image quality, and patient education. The development of CPGs has a potential impact on
social change by addressing others’ needs, using trustworthy sources for research, and
developing guidelines that address cultural consideration of the target population.
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Section 1: Nature of the Project
Introduction
Radiation therapy for the treatment of cancer can have toxic effects on both
cancerous and healthy tissue (Graf, Boehmer, Nadobny, Budach, & Wust, 2012).
Particular setup can help reduce toxic exposure of radiation to healthy tissue. An
adequate setup that spares noncancerous tissue can reduce lifelong bowel, bladder, and
sexual function complications for prostate cancer patients (Tsang & Hoskin, 2017).
However, there are no clinical practice guidelines (CPGs) for best practice interventions
for prostate radiation setup at the practice site. With this project, I aimed to determine
what best practices contribute to a CPG for setting up patients with prostate cancer
undergoing radiation therapy treatment. CPGs improve care equity, reduce variations in
care, assist in social change, and define best healthcare practices (Kredo et al., 2016).
CPGs also allow the nurse to identify barriers and choose more appropriate and
achievable interventions (Institute of Medicine [IOM], 2011).
Problem Statement
The practice problem addressed in this project was the inadequate preparation of
prostate cancer patients undergoing radiation therapy, starting with the planning of the
computerized tomography (CT) scan. This scan is required before beginning the 8-week
radiation treatment (Johns Hopkins Medicine, n.d.). This planning session is referred to
as a simulation. Patients must understand the importance of adequately preparing for the
planning CT because when patients are inadequately prepared for simulation; multiple
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CT scans may be required, resulting in increased radiation exposure for the patient and
delays in the CT scanner schedule. In the specialty of radiation oncology, proper setup
and immobilization for treatment are of utmost importance to reduce prostate motion;
reduced prostate motion has been shown to minimize damage to healthy tissue during
treatment (Darud, Giddings, Keyes, McGahan, & Tyldesely, 2010). Damaging healthy
tissue can contribute to short- and long-term side effects caused by the treatment
(Maggio et al., 2017). Treatment for prostate cancer requires that the patient has a full
bladder and rectum empty of stool and flatulence (Yaver, 2015). Adequate bowel and
bladder setup reduces prostate movement during therapy and has been associated with
improved clinical disease-free survival (Darud et al., 2010; Maggio et al., 2017).
The first opportunity patients have to experience this setup is during the
simulation appointment. Simulation for radiation therapy treatment is a nondiagnostic
CT scan for planning purposes where the patient is positioned like the patient is getting
radiation treatment (Johns Hopkins Medicine, n.d.). These patients must duplicate this
alignment preparation every day, 5 days a week, for 8 weeks (Memorial Sloan Kettering
Cancer Center, n.d.). Due to the combination of the difficulty of obtaining a full bladder
and an empty rectum and the importance of this setup, patients often do not obtain the
correct setup during simulation (Maggio el at., 2017). When patients cannot adequately
set up, they need to be resimulated, which consists of an extra CT scan and, therefore,
additional radiation to healthy tissues. The waiting period can be uncomfortable for the
patient. Additionally, these patients are likely to be rescheduled later in the same day as
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their first scan, which requires them to spend a significant amount of time in the clinic
awaiting resimulation.
At the project site, there are currently no CPGs for prostate cancer presimulation
interventions. In this project, I addressed this gap through the creation of a CPG for use
at the clinic. In this setting, nurses are responsible for educating patients regarding
radiation treatment and initiating interventions, such as bowel and bladder preparation
regimen, for preparing the patient for successful simulation. Developing a CPG can help
support nurses to prepare the patient better to implement these interventions.
Purpose Statement
The purpose of this doctoral project was to address the gap in practice related to
the lack of a standardized process for implementing presimulation interventions for
patients with prostate cancer undergoing radiation therapy by developing an evidencebased CPG. The practice problem addressed in this project was the inadequate
preparation of prostate cancer patients undergoing radiation therapy for their planning CT
scan. The guiding practice-focused question for this doctoral project was: What best
practices contribute to a CPG for preparing patients with prostate cancer undergoing
radiation therapy treatment? I intended this doctoral project to address the gap in practice
by evaluating the quality of literature currently available on interventions to minimize
prostate movement and reduce radiation to healthy surrounding tissue and practically
synthesizing the evidence into a CPG.
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Nature of the Doctoral Project
CPGs are statements developed to optimize patient care informed by a systematic
review of the evidence (Kredo et al., 2016). A panel of experts and key stakeholders
should be involved in developing CPGs (IOM, 2011). For this project, I used peerreviewed articles involving experimental and observational studies and systematic
reviews, expert opinion, and publically available patient education materials from
National Cancer Institute-designated organizations for the past 5 years. I obtained these
resources by searching databases, including CINAHL, MEDLine, Embase, and ProQuest.
Additionally, Google Scholar was searched for other resources. I consulted with prostatespecialized radiation oncologists and included them in the project team to obtain expert
opinions. The Johns Hopkins nursing evidence-based practice (JHNEBP) model was used
to grade the evidence and associated tools to synthesize and organize the evidence. Once
the CPG was developed, it was appraised by the project team using the Appraisal of
Guidelines for Research and Evaluation (AGREE) II instrument to verify that the
guidelines were methodologically rigorous and free of bias. The project team determined
how the guideline needed revision and then presented it to stakeholders. This process
enabled the doctoral project to fulfill its purpose and fill the gap in practice involving the
lack of clinical guidelines for prostate cancer presimulation interventions.
Significance
The impact of patients being inadequately prepared for simulation reaches across
disciplines. Patients can get frustrated by the process when unprepared, undergo multiple

5
CT scans, and be delayed until later in the day. Nurses are impacted by the lack of
standardized presimulation interventions and are searching for different techniques to
best help patients with issues involving the need to be frequently reeducated. Radiation
therapists must rearrange the machine schedule when patients are delayed due to
inadequate preparation. Front desk staff are affected by apologizing and attempting to
preserve customer satisfaction for other patients still awaiting their now delayed
treatments. Radiation oncologists may face backlash from staff and patients because of
the frustration with the process.
Besides having a direct impact on the local clinic, the development of a CPG for
patients undergoing prostate radiation can contribute to nursing practice by reinforcing
the concept that nurses can practice to their fullest scope by coordinating care and
symptom management. Nurses may find this guideline beneficial in acting as the
multidisciplinary leader in ensuring patients have various interventions to improve
outcomes. Furthermore, the project team’s findings in the doctoral project can expand the
base of professional nursing knowledge.
The development of this CPG has the potential for transferability to other
practices outside of the project site clinic. The guidelines can be locally transferred to
other clinics within the health system for patients with prostate cancer. On the Oncology
Nursing Society discussion board (https://communities.ons.org/), the topic of bowel and
bladder preparation comes up frequently. Within the United States, there are no societal
or publicly available guidelines that address presimulation interventions for patients
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undergoing prostate radiation therapy, so there is potential for national transferability as
well. The Global Cancer Observatory (2018) reported that prostate cancer is the second
most common cancer in men globally and is expected to increase in prevalence over the
next 2 decades. While the guidelines may recommend interventions or techniques that are
not currently available everywhere globally, there is great potential for international
transferability for most clinical guidelines. Especially in areas where imaging technology
is not as advanced, it is important to reduce prostate motion; reducing prostate motion
can spare healthy tissue and improve mortality (den Harder, van Gils, Kotte, van Vulpen,
, & Lips, 2014).
Developing CPGs has potential implications for positive social change by
establishing evidence-based interventions in an easy-to-use format for use in small,
generalized radiation clinics and large, highly specialized academic institutions.
Additionally, this project aligns with Walden University’s (2017) mission for social
change by addressing others’ needs, using trustworthy sources for research, and
developing inclusive guidelines that address cultural consideration of the target
population.
Summary
Undergoing cancer treatment can be frightening and anxiety-producing for
patients; therefore, patients must trust the healthcare team to provide the best treatment.
However, finding the best evidence-based practices (EBPs) can be time-consuming and
often confusing for the healthcare team. CPGs can quickly guide practitioners to
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evidence-based interventions for specific situations. In Section 1, I described the gap in
practice and project question, the nature of the project, and the significance of the project
to stakeholders. In Section 2, I will introduce the model that framed the project, the
evidence supporting the project, and my role in the CPG development.
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Section 2: Background and Context
Introduction
Preparing patients undergoing radiation oncology to set up the same way every
day for treatment is important to ensure they receive the planned radiation to cancerous
tissue. This setup can be obtained with special pillows, masks, and surgical interventions
(Memorial Sloan Kettering Cancer Center, n.d.). Patients receiving radiation for prostate
cancer have a challenging setup; they must have an empty rectum and a full bladder, and
often, they struggle with or cannot obtain an appropriate setup for treatment (Maggio et
al., 2017).
The practice problem addressed in this project was the inadequate preparation of
prostate cancer patients undergoing radiation therapy for the planning session. There are
no standardized procedures to guide staff to help prepare the patients for setup. Through
this project, I sought to identify evidence to support the development of a CPG for
presimulation preparation for patients with prostate cancer undergoing radiation therapy.
Identifying the information and developing a CPG addressed the gap in practice
involving the lack of a standardized process for implementing presimulation interventions
for prostate cancer patients undergoing radiation therapy. In this section, I review the
following related to the development of CPGs: guiding theories and models, relevance to
nursing practice, the context of implementation, and the role of the DNP student.
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Concepts, Models, and Theories
Healthcare providers are tasked with giving patients the best care; unfortunately,
providers do not always have quick access to evidence-based guidelines that support that
goal. CPGs are evidence-based references for healthcare providers. According to Jeffs et
al. (2013), nurses prefer to receive evidence-based information presented in an easy-tounderstand and succinct format. Jeffs et al. identified three factors necessary to address
when presenting evidence-based interventions to nurses: (a) the information needs to be
easy to take in, (b) specific to the population/care provided by the staff, and (c) come
from substantial sources.
The model used to guide the development of the CPG for this project was the
JHNEBP model. The JHNEBP model is used to evaluate the level and quality of each
evidence source, summarize the evidence, and then synthesize the collective evidence for
quality and strength (Dearholt & Dang, 2012). One benefit of using the JHNEBP model
is the inclusion of internal and external forces (i.e., regulatory and accreditation bodies)
when considering the application of identified best practices. The model also supports
users through problem identification, gathering evidence, and translating into practice
(Dearholt & Dang, 2012). The first 10 steps of the JHNEBP model are applicable to the
CPG development process:
1. Recruit interprofessional team.
2. Develop and refine the EBP question.
3. Define the scope of the EBP and identify stakeholders.
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4. Determine responsibility for project leadership.
5. Schedule team meetings.
6. Conduct internal and external searches for evidence.
7. Appraise the level and quality of each piece of evidence.
8. Summarize the individual evidence.
9. Synthesize overall strength and quality of evidence.
10. Develop recommendations for change based on evidence synthesis (Dearholt
& Dang, 2012, p. 226).
Steps 11–18 focus on the translation of evidence into practice and dissemination of
findings (Dearholt & Dang, 2012).
Relevance to Nursing Practice
While large professional organizations like the American Society for Radiation
Oncology have not developed CPGs for bowel and bladder regimens for prostate cancer
patients, there is evidence in the literature for independent interventions for simulation
preparation. Waddle et al. (2018) presented bladder regimen filling recommendations
that focused on the importance of extra counseling for patients older than 70 years old.
Yahya et al. (2013) compared dietary guidelines, microenemas, and no preparation and
found microenemas were significantly (p < 0.001) superior to reduce prostate motion
during treatment. Darud et al. (2010) found no significance in prostate motion between a
full bladder with an empty rectum protocol and a full bladder with no specified rectum
protocol. Graf et al, 2012) presented data on patient instructions for bladder filling and
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the placement of fiducials (i.e., invasively placed gold markers that are used to indicate
the location of the prostate on imaging scans) compared to skin marks for reducing
prostate movement. Additional sources of evidence include expert recommendations
found in patient education materials from large cancer centers, such as Memorial Sloan
Kettering Comprehensive Cancer Center (n.d.), which recommended using psyllium 7
days before simulation and a Fleet enema 3 hours before simulation. Additionally, Rogel
Cancer Center (2017) recommended bladder filling by voiding 1 hour before the
simulation appointment and drinking two and a half cups of water. The amount and
variation of evidence indicate that radiation oncology specialists continue to search for
presimulation interventions for patients undergoing radiation treatment for prostate
cancer.
Medves et al. (2010) identified that CPGs are a way to improve overall care as
evidenced by improved patient outcomes, patient care, staff satisfaction, and costeffectiveness. The IOM (2011) reported that CPGs are useful in specialized areas as
recommendations but not as rules. Currently, there are no published guidelines on
interventions to help patients with prostate cancer prepare for simulation. Because the
providers do not write orders for the bladder and bowel protocol, nurses are left to
attempt trial and error to help patients prepare based on experience.. Boehmer et al.
(2006) were unable to reach a consensus on best practices to help set patients up for
treatment.
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Nurses in radiation therapy maintain responsibility for helping patients prepare for
treatment. For patients with prostate cancer, the nurse provides presimulation
interventions to help reduce prostate movement and, therefore, toxicity during and after
treatment. Boehmer et al. (2006) identified several dosimetric guidelines to reduce the
irradiation of healthy tissue but could not provide guidelines on bowel and bladder
regimens to reduce toxicity. Since Boehmer et al.’s guidelines were published, more
studies have been conducted to identify the appropriateness of individual interventions.
For example, there are several studies assessing bladder filling protocol. Most of the
studies are aimed at identifying the appropriate volume of fluid to consume to obtain a
full bladder (e.g., Braide et al., 2019; Maggio et al., 2017; Nathoo et al., 2018), but Tsang
and Hoskin (2017) identified that there was no statistically significant difference for acute
and intermediate toxicities in terms of empty and full bladders for prostate radiation. To
develop a CPG for this project, I collated these individual recommendations into one
easy-to-navigate document for radiation oncology nurses.
Local Background and Context
Evidence from the project site that supports the relevance of the problem at the
local level manifests as delays in schedules due to inappropriate preparation for
simulation, patient-reported qualitative comments obtained from the online patient
satisfaction survey, and nurse displeasure at the situation taken from the employee
engagement survey and clarified during a nurse-only meeting on results. Nurses viewed
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the lack of standardized guidelines for prepping patients for prostate radiation therapy as
evidence of not having the tools required to complete the job.
The identified setting for this project site was the radiation oncology department
of a large academic health system in a sizeable metropolitan area in the northeast United
States. This department encompasses six clinics, including four hospital-based and two
satellite campuses. This project was completed in one of the hospital-based clinics that
manages the majority of the patients with prostate cancer. This clinic supports a hospital
that meets the local urban community’s needs and is a destination hospital for national
and international patients.
There was support for this project from departmental leadership, prostate
radiation oncology specialists, and the primary nursing team that supports these patients.
Stakeholders consisted of prostate radiation oncologists, RNs, a clinical coordinator, a
clinical nurse specialist, radiation therapists, clinic administration, and patients. Between
the two full-time prostate care providers at the project site, approximately 32 patients are
consulted for treatment per month, with about 25 patients actively receiving treatment at
any given time. Current practice for how patients are educated to prepare for simulation
varies depending on the radiation oncologist and the nurse consulting the patient. For
example, one provider recommends that the patient voids 1 hour before simulation then
sips 32 ounces of water, and another provider tells the patient to void and then drink
until his bladder is comfortably full. Another variation is the recommended bowel
regimen: One provider suggests taking sennoside-docusate, while the other recommends

14
psyllium. Practice varies between nursing staff with one of the primary prostate care
nurses calling patients either the Monday or Wednesday before simulation to review the
bowel and bladder protocols, while the other hands the protocols to the patient, on a
sheet of paper, at the time of consultation.
Role of the DNP Student
I have been employed by the project site for 3.5 years as the clinical nurse
specialist in radiation oncology. In my role, I monitor metrics such as patient satisfaction,
clinic productivity numbers, and safety metrics. I work across all six clinical sites to
standardize processes, policies, and procedures to improve patient safety and quality of
care. I am consulted to help with complex patient cases and have been asked by the
multidisciplinary team to identify best presimulation practices to improve the ability of
patients with prostate cancer to complete their treatment planning on the first attempt.
With my training on EBP and project management, I led the project to identify best
practices and applicability to the project site. I worked with the multidisciplinary team to
better understand CPG implementation barriers to address these barriers during the CPG
development process.
My motivation for this doctoral project came from several factors. First, I was
concerned about nurse job satisfaction. Our nurses reported in the employee engagement
survey that they do not have the tools they need to do their job. The primary prostate care
team nurses have also verbalized dissatisfaction with informing prostate patients on how
to prepare for simulation. Providers have different expectations for patient preparation,

15
and the nurses are keenly aware that the interventions they are instituting are not evidence
based. Another motivation for this project was the patients’ quality of life. Patients
anecdotally report how uncomfortable and challenging it is to maintain a full bladder and
empty rectum. Patients have even more difficulty maintaining the full bladder when there
is a delay in the treatment schedule. Delays as short as 15 minutes have resulted in
episodes of incontinence. Being incontinent can be a mortifying experience for patients
and further delay that patient’s treatment while the patient’s bladder refills. Finally, I am
driven by clinic efficiencies. When one patient with prostate cancer is delayed, it creates
what staff calls a domino effect, and all of the other patients with prostate cancer are
delayed. When the prostate patients are delayed, they have challenges holding a full
bladder, often void, and then restart the bladder filling process. My wide-ranging
motivations led me to want to create the CPG and combat any bias I may have
contributed to the project, and to mitigate this bias, I selected expert project team
members to evaluate the CPG using the AGREE II instrument.
Role of the Project Team
The project team was an interdisciplinary team consisting of me, the radiation
therapy director, a radiation oncology nurse specializing in prostate cancer, and a prostate
radiation oncologist. I contacted the various team members in person, and they agreed to
participate in the project. Before the first meeting most of the literature was collected and
the grading process had started. The team first met to review the literature and grading of
evidence based on the JHNEBP model. At the start of the project, the plan was for the
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team to meet weekly, either in person or virtually, to review progress on grading and
evaluating the literature for recommendations. The group was not able to meet as
frequently as planned due to the COVID pandemic. At the start of project
implementation, the team debriefed on the practice problem and current practice at the
practicum site and were educated on the AGREE II instrument for CPG evaluation. The
individuals in the group also shared their experiences with the practice problem. They
provided contextual insight into the challenges surrounding the problem and helped
identify potential barriers to implementing interventions recommended by the literature.
Summary
Previous research on presimulation intervention focuses on individual
interventions, but there is no evidence in the literature about attempts to combine best
practices into CPGs for presimulation interventions for patients undergoing radiation
therapy for prostate cancer. In Section 2, I described how the JHNEBP model can guide
project teams to collect and synthesize evidence for the development of CPGs. In this
section, literature was reviewed to highlight the importance of this project to nursing
practice and the role of the DNP scholar and the project team were described. In Section
3, I will discuss how evidence was collected, analyzed, and how the team validated the
CPGs.
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Section 3: Collection and Analysis of Evidence
Introduction
The purpose of this doctoral project was to address the gap in practice of the lack
of a standardized process for implementing presimulation interventions for patients with
prostate cancer undergoing radiation therapy by developing an evidence-based CPG.
Kredo et al. (2016) described CPGs as a way to present concise information to improve
efficiencies and close the gap in practice with available scientific evidence. In the last 5
years, researchers have identified best practices for individual interventions to improve
patient setup for simulation for radiation therapy (Tsang & Hoskin, 2017), but no
guidelines have been developed to recommend a collection of best practices. In this
section, I review the practice-focused question and the process involved with collecting
and analyzing evidence sources.
Practice-Focused Question
There are no societal or publicly available CPGs for setup for treatments to help
nurses prepare patients with prostate cancer undergoing radiation therapy. At the
practicum site, nurses have verbalized frustration at the lack of standardization and
absence of guidelines for helping patients prepare for prostate radiation therapy. The
practice question for this project was: What best practices contribute to a CPG for
preparing patients with prostate cancer undergoing radiation therapy treatment? MooreHiggs et al. (2003) reported that since the early 1990s, the radiation oncology nurse’s role
consisted of independently managing symptoms through nonpharmaceutical means as
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well as work in close collaboration with the radiation oncologist for
pharmaceutical/interventional symptom prevention and management. Without standard
CPGs for presimulation interventions, nurses are challenged to provide consistent,
evidence-based interventions for these patients.
Sources of Evidence
To address the practice-focused question, I collected evidence published within
the last 5 years. Evidence from expert opinion is not sufficient alone to address the gap in
practice of the lack of a standardized process for implementing presimulation
interventions by developing an evidence-based CPG. For this project, I followed the
guidelines in the Walden University (2019) Manual for Clinical Practice Guideline
Development. The sources of evidence used included primary sources (i.e., original
works of evidence obtained through research), translational literature (i.e., CPGs), and
evidence summaries like systematic reviews (see Dearholt & Dang, 2012).
I conducted a literature review using databases accessible through the Walden
University Library, including CINAHL Plus with Full Text, MEDLINE with Full Text,
PubMed, Ovid Nursing, Embase, ProQuest Nursing and Allied Health Source, and
Google Scholar. The following terms were used in the literature search: prostate,
prostate cancer, radiation therapy, radiotherapy, simulation, bladder filling, bladder
regimen, bladder protocol, bowel emptying, bowel regimen, bowel protocol, fiducials,
prostate motion, clinical practice guideline, AGREE II, implanted rectal spacer, and
hydrogel. Additionally, the Boolean strings and/or were used to carry out a more
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comprehensive search. From the results, I completed citation chaining to ensure a
thorough search and identify historical research. Publication years were initially limited
to 2014–2019, but I also conducted an additional search to update any articles added in
2020 to include all up-to-date articles. Sources of evidence were not be limited to those
published in the United States, so spelling variation was included to account for
international studies.
The evidence found in the literature review helped meet the purpose of this
doctoral project by addressing the gap in practice of no standardized process for
implementing presimulation interventions for patients with prostate cancer undergoing
radiation therapy. This doctoral project addresses the gap in practice by evaluating the
quality of literature currently available on interventions to minimize prostate movement
and reduce radiation to healthy surrounding tissue. I used the tools provided by the
JHNEBP model to organize and guide the analysis of the evidence. The grading and
scoring of the evidence in the literature review using the JHNEBP model is located in
Appendix A. After evaluating the quality of the evidence, it was synthesized into a CPG.
I maintained ethical protections during the doctoral project by following the
Walden University (2019) Manual for Clinical Practice Guideline Development. The
project was submitted to the Walden University Institutional Review Board and approved
(approval number 01-02-20-0974445) before data were collected. No patient personal
health information data were gathered, stored, or utilized for this project.
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Analysis and Synthesis
After developing the proposed guideline, the project team reviewed the guideline
using the AGREE II instrument. The AGREE II instrument is a validated and reliable
tool containing 23 questions, organized into six different domains, that aims to evaluate
whether guidelines are free of bias and have been developed methodically and
rigorously (AGREE Trust, n.d.). I revised the proposed guideline based on the panel’s
recommendations and had them complete a second review. Once the CPG was finalized
and the doctoral project was completed, the proposed guidelines were shared with clinic
administration, and upon their approval, with the multidisciplinary team.
Summary
In Section 3, I described the participants, procedures, and protections that
supported this project. The process of analysis and synthesis was also presented. In
Section 4, I will review the findings and recommendations from the development of the
CPG.
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Section 4: Findings and Recommendations
Introduction
Appropriate preparation and setup for prostate cancer radiation therapy can reduce
damage to healthy tissue; however, there is a gap in practice that front-line staff has no
standardized guidelines from the practice site or industry leaders to prepare patients for
prostate therapy setup. The practice-focused question for this project was: What best
practices contribute to a CPG for preparing patients with prostate cancer undergoing
radiation therapy treatment? The purpose of this doctoral project was to address the gap
in practice of the lack of a standardized process for implementing presimulation
interventions for patients with prostate cancer undergoing radiation therapy by
developing an evidence-based CPG.
The sources of evidence used to create the CPG were primary sources that
included translational literature, evidence summaries like systematic reviews, and expert
opinion. I obtained evidence through a review of the literature with the publication years
of 2014–2020 using databases accessible through the Walden University Library.
Additional evidence was added to the results by citation chaining to ensure a thorough
search. I then evaluated the results using the JHNEBP model for evidence level and
quality of the study. Recommendations for inclusion in the CPG were considered based
on quantity, quality, the patient feedback reported in the studies, financial impact, and
potential applicability into the clinic.
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Findings and Implications
The project team reviewed and analyzed the CPG for validity using the AGREE II
instrument. I used the AGREE II instrument instructions to score the CPG based on the
project team’s evaluation. Each project team member, when asked to participate in the
project, was introduced to the concept of the AGREE II method. After developing the
CPG, I reviewed the AGREE II instrument with each team member and gave them each a
copy of the AGREE II instrument, the CPG, and the literature review. The project team
members were to return their completed AGREE II tools within 1.5 weeks; however only
1 of the 3 finished it in that period. Two team members needed an additional 2.5 weeks to
complete the AGREE II instrument. Two of the project team members supplied
comments in addition to their scores of the questions, and the third team member made
no comments. The individual reviewers’ scores are presented in Table 1.
The AGREE II instrument contains 23 questions, organized into six different
domains, followed by two items that assess the overall score and recommendation for
using the CPG evaluated (AGREE Research Trust, n.d.). Each item within the domains
are rated as 1 (strongly disagree) to 7 (strongly agree). However, scoring is represented
as a percentage by each domain and is calculated by totaling the obtained score: The
minimum possible score over the maximum possible score for the domain minus the
minimum possible score ( Brouwers et al., 2010). Overall, the expert panel recommended
the CPG be published with modifications.

23
Table 1
Results of the AGREE Instrument Provided by the Expert Project Team
Domain
Domain 1
Item 1
Item 2
Item 3
Domain 2
Item 1
Item 2
Item 3
Domain 3
Item 1
Item 2
Item 3
Item 4
Item 5
Item 6
Item 7
Domain 4
Item 1
Item 2
Item 3
Domain 5
Item 1
Item 2
Item 3
Item 4
Domain 6
Item 1
Item 2
Total
Overall Guideline Assessment
Item 1
Item 2

Expert 1

Expert 2

Expert 3

7
7
7

3
4
7

6
7
7

7
5
6

4
3
7

5
5
7

7
6
7
6
5
6
5

7
7
7
7
7
7
6

7
6
7
7
6
6
6

7
6
7

6
7
7

6
7
7

5
6
4
4

6
7
3
2

7
7
5
6

7
6
52

7
7
52

7
5
57

6
Yes

6
Yes with
modification

6
Yes with
modification
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Domain 1
Domain 1 of the AGREE II instrument focuses on identifying the robustness of
the scope and purpose of the CPG (Brouwers et al., 2010). This section has three
questions, and the project team scored Domain 1 as 85.19% overall. One reviewer asked
for a clarifying comment about the goals of the CPG. During the review process, the
project team members’ answers were blinded to me; however, the nurse team member
followed up after submitting her responses to state that she understood the goal of the
CPG but was seeking more clarification on the downstream effects of the implementation
of the CPG.
Domain 2
Domain 2 of the AGREE II instrument focuses on identifying the extent of
stakeholder involvement (Brouwers et al., 2010). This section also has three questions;
the overall score for Domain 2 in this project was 74.07%. One area of improvement
noted was that the views of the target population had been obtained through the literature
review findings and that there were limitations within the studies used to develop the
CPG.
Domain 3
Domain 3 of the AGREE II instrument concentrates on the rigor of developing the
CPG (Brouwers et al., 2010). This section contains eight questions; however, one
question was excluded in this project as the CPG lacked a procedure for updating the
guideline. When the CPG is finalized, the supporting organization will determine an
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appropriate procedure and frequency for updating the CPG. The overall score for Domain
3 was 90.48%. Comments in this section reflected that the reviewers observed the
recommendations were clear and based on the literature review.
Domain 4
Domain 4 of the AGREE II instrument sought to identify the clarity of the
recommendations and management presentation (Brouwers et al., 2010). Domain 4
comprised three questions and was the highest-scoring domain from the reviewers at
94.44%. The project team commented that the recommendations were clear and specific,
and key recommendations were easy to read in the table format.
Domain 5
Domain 5 of the AGREE II instrument assesses the applicability of the CPG to
practice, and there are four questions in this domain (Brouwers et al., 2010). The overall
score for this domain was 69.45%. The project team made comments in the AGREE II
instrument of additional barriers, such as cost information that the CPG did not address.
The project team also pointed out that there was a lack of description of how users would
measure the CPG as successful.
Domain 6
Domain 6 of the AGREE II instrument focused on assuring there was editorial
independence in that the CPG was free from competing interests or those interests were
recorded (Brouwers et al., 2010). Domain 6 has two questions, and the overall score was

26
80.49%. The reviewers commented that it was clearly stated that there were no
competing interests from funding bodies.
Overall Guideline Assessment
The overall guideline assessment section in the AGREE II instrument is
comprised of two questions (Brouwers et al., 2010). The first question was to rate the
overall quality of this guideline on a scale of 1 (lowest possible quality) to 7 (highest
possible quality), and the reviewers unanimously scored this question a 6 out of 7. The
second question was “I would recommend this guideline for use.” Reviewers could
choose: yes; yes, with modifications; or no. One reviewer chose yes, while the other two
chose yes, with modifications. No reviewers added notes or comments in the overall
guideline assessment section.
One area outside the scope of the development of this CPG was updating the
CPG. When a final determination for long-term ownership of the CPG is made, the
procedure will be added based on that organization’s practices. Another limitation was
the lack of cost analysis in the literature review on the various interventions guiding the
recommendations; this limitation was reflected in the project team’s scoring.
The CPG analysis shows that there are EBPs to develop a CPG to guide radiation
oncology healthcare workers to choose more appropriate interventions to improve the
planning session for prostate radiation therapy. This can positively impact individual
patients by improving their therapy planning session, the population of radiation
oncology patients by improving clinical flow, and healthcare institutions by improving
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the workflow to the point of cost avoidance. The potential implication for positive social
change is that by making this CPG available through publication, easy-to-use, evidencebased interventions would be made available to patients worldwide, from small,
generalized radiation clinics to large, highly specialized academic institutions.
Recommendations
Within the CPG, recommendations are broken down into four categories: bladder
management, bowel management, imaging/treatment quality, and patient education. By
implementing these practice guidelines, radiation oncology practitioners have a
standardized tool that they can use to inform interventions for every patient’s
presimulation. Additionally, the CPG provides secondary recommendations, which may
be used for patients who need additional interventions and should not be considered for
every patient.
Bladder management interventions had the widest variety of practices in the
literature; however, the recommendations that were made in the CPG had some of the
strongest studies supporting the findings. Recommendations include having the patient
empty their bladder, then drink 500 mL of water finishing 60 minutes before the
simulation/treatment (see Maggio et al., 2017, Nathoo et al., 2018; Holden, Stanford,
D’Alimonte, Kiss, & Loblaw, 2014). Fujioka et al.’s (2016) findings informed the
recommendation that a goal bladder volume on ultrasound is between 100 mL and 250
mL at the time of the simulation. The final recommendation for bladder management is
for individuals undergoing prostate radiation to consume at least 1.5–2L of water daily
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(see Oates et al., 2014; Smitsmans et al., 2017; Sunshine Coast Hospital, 2017; Yaver et
al., 2015). Bladder management is one category of interventions for presimulation for
patients with prostate cancer. Another important category is bowel management.
Proper bowel management helps keep the bowel away from the area receiving
radiation for patients receiving prostate radiation (Yaver et al., 2015). Specifically,
patients should have an empty rectum for treatment; to accomplish this, they should have
a bowel movement daily and pass flatulence 1 to 2 hours before treatment (Maggio et al.,
2017; Rogel Cancer Center, 2016). Patients should eat an antiflatulence diet by avoiding
fermentable carbohydrates, carbonated beverages, dairy, and high-fat foods (Cancer
Center of Santa Barbara, 2017; Hosni et al., 2017; Oates et al., 2014; Smitsmans et al.,
2017). Patients should also change their eating style to improve gas management; they
can do this by reducing aerophagia (i.e., excessive and repetitive air swallowing; Cancer
Center of Santa Barbara, 2017; Oates et al., 2014; Smitsmans et al., 2017; Sunshine Coast
Hospital, 2017). Additional steps for bowel management include taking an osmolotic
laxative nightly, starting 5 days before simulation, and continuing throughout treatment
and reducing as needed for excessive stools (Bayles, 2015; Sunshine Coast Hospital,
2017; Weston, 2019). Take a Fleet enema if unsuccessful with other interventions to have
a bowel movement daily, or if the rectum is greater than 3.5 cm on simulation CT
(McNair et al., 2011Memorial Sloan Kettering Cancer Center, 2018). The final
recommendation for bowel management is to increase exercise daily to promote bowel
motility (Oates et al., 2014; Smitsmans et al., 2017; Sunshine Coast Hospital, 2017). In
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addition to bowel and bladder recommendations for patients, there are imaging/treatment
recommendations and patient education recommendations that radiation therapy teams
can use to help patients be successful with simulation.
A recommendation to improve imaging quality is to give patients consistent
appointment times; this allows them to get into a routine and have them set up the same
(see Yaver et al., 2015). Providers can also consider the use of interstitial biodegradable
balloons (i.e., hydrogel spacers); when hydrogel spaces are used, they should be injected
at least 3–5 days before the patient is simulated (Uhl et al., 2013). As techniques
improve, there is still a basic human connection between patients and providers, and
patient education has an important role in preparing patients for their simulation.
Radiation oncology staff should provide verbal and written specialized patient
education to patients (McGuffin et al., 2018). Whenever possible, add appropriate images
to patient education; customizing the images to the treatment center will help patients
associate what they were taught and may help them feel more comfortable (Osmar &
Webb, 2015). When providing education, radiation oncology staff should speak with
plain language, use analogies, and repeat information; if patients need clarity, direct them
to a radiation oncologist, and confirm the patient’s understanding with the teach-back
method (Schnitzler et al., 2017). The full CPG is located in Appendix B for reference.
Contribution of the Doctoral Project Team
At the start of the project, the doctoral project team was contacted about
participating in the project. The project team consists of me, the radiation therapy
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director, a primary prostate cancer radiation oncology nurse, and a prostate radiation
oncologist. Project team members informed me of potential interventions/keywords to
include in the literature review when searching for best practices based on disciplinespecific interventions. At the start of the project, the intention was to have the team meet
in person; however, limitations imposed by COVID-19 and team member schedules
prevented this, and I met individually with team members regarding the project. After I
completed the literature review and grading of the articles using the JHNEBP model,
individual meetings with the project team members occurred to review findings and
identify potential recommendations based on quality and frequency of evidence. After the
CPG was developed, the project team assessed the CPG with the AGREE II instrument
for validity. The prostate expert physician team member verbalized the importance of the
CPG and DNP project findings. He noted that he felt for radiation oncology professional
organizations to accept the CPG, the CPG would have to have more depth, and the
current version of the CPG would be a good summary for the overall CPG to be
published.
After the DNP doctoral project, the project site and project team members have
expressed interest in researching the CPG recommendations. The team would like to
compare the standard of care (no defined interventions) and the application of the CPG
recommendation. They propose measuring success by evaluating the frequency patients
undergoing radiation for prostate cancer need to have cone-beam CT images before
treatment. Additionally, the team would like to explore areas the CPG could not cover
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based on the literature review and findings from primary sources such as financial
implications. They also recommended engaging a focus group, which is outside of the
scope of this DNP project.
Strengths and Limitations of the Project
This doctoral project had several strengths as well as limitations. Strengths
included project site support, from front-line staff to the department chairperson staff at
this project site, recognizing the problem addressed in the project, and supporting the
effort to address it. Additionally, there was a sufficient of literature to help answer the
project focus of what best practices contribute to a CPG for setting up patients with
prostate cancer undergoing radiation therapy treatment. Strengths and limitations of the
project include the project team; the team was able to give different viewpoints about the
gap-in-practice. Nevertheless, a delay in the project occurred during the literature review
phase when I was the only team member who knew the grading and scoring for literature
using the JHNEBP model.
Recommendations for future CPG development projects include having a
moderate-sized interdisciplinary project team. Additionally, consider using mind
mapping to help organize recommendations from the literature review. Finally, for topics
that seem to have limited research available, citation chaining helps identify additional
sources of evidence and potential key search terms.
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Section 5: Dissemination Plan
Introduction
The first step in the plan to disseminate this CPG to the institution experiencing
this practice problem is to present this to the leadership team. Simultaneously, I plan to
present the CPG to the nurses supporting patients receiving prostate radiation and their
providers. Many team members may ask for the supporting information for the CPG, so it
will be important to have the literature review grid available and the references to the full
articles that informed the recommendations. The intended audience is a relatively small
group of less than 10 individuals. To sustain the dissemination of this information to
incoming nurses to the department, the CPG will be added to the nursing orientation
binder.
Radiation oncology nurses caring for patients receiving prostate cancer treatment
are the primary audience for this CPG. Radiation oncology residents, therapists, or
radiation oncologists may also find the CPG beneficial. The CPG would also be
appropriate to disseminate to the Oncology Nursing Society through the national
convention and through journal articles to reach their primary audience. Another avenue
of dissemination could be through advanced practice nurses and their respective society
Advanced Practitioner Society for Hematology and Oncology, journals, and conventions.
Analysis of Self
Reflecting on my roles while completing the doctoral project, I was able to apply
the academic skills I obtained in the DNP program and exercise project management
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techniques. Using these skills outside my assigned job duties helped prepare me for
future endeavors where I may lead an organization-based team/project. The doctoral
project was the first time I created a CPG, and I found the entire process very rewarding.
I think providing nurses with EBPs can profoundly impact the patient, nurse, and
organization/system.
I had anticipated challenges with the completion of this project but nothing to the
extent that COVID-19 presented. Initially, I had planned to take time off work to devote
to working on the project; however, COVID-19 expanded my working hours as well as
those of the project team. We experienced shifted job responsibilities and increased
workloads even after the risk had seemed to level out. I had to meet with the project team
virtually, not physically seeing some of the team members for months. This lack of a
visual reminder of scheduled tasks also meant I had to e-mail the team to remind them to
complete and return the completed tools. It was a good practice of holding teammates
accountable to a timeline regardless of rank and, at times, required flexibility.
Completing this project has given me insight into how to be a better project manager and
that CPGs are important and useful for nurses. Additionally, I learned that with the right
team and adequate time, developing a CPG is not that challenging.
Summary
Complex treatments can require complex interventions. The setup for patients
receiving radiation for prostate cancer is complex, and currently, there are no
organizational guidelines to help guide interventions for prostate radiation setup. CPGs
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are a way to provide nurses with evidence-based interventions and improve overall care
as evidenced by improved patient outcomes, patient care, and staff satisfaction (Medves
et al., 2010). With the support of a project team, I identified which EBPs were supported
in the literature and then created a CPG for the preparation for patients undergoing
radiation for prostate cancer. The project team validated this CPG using the AGREE II
instrument. The CPG will be shared with a broader base of oncology nurses, outside of
the project site, in the future through conferences.
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Rifaximini – not
been
demonstrated to
reduce rectal
exertion of
flatulence
Enemas –
reduces
geometric
misses by >5
mm, highly
efficient at
limiting prostate
motion

No strong
recommendations,
one reviewer,
inconsistent
definitions
between studies

VB

45
invasive-repeated
daily for treatment
Rectum empting
tube (RET)- possible
incorrect placement,
invasive-repeated prn
for treatment
Laxatives
Polyethylene glycolmost effect in stool
frequency and
formation and faster
Senna-lack of
placebo control in
studies
EnemasRecommending in
areas where use of
CBCT is limited, used
for short duration such
as RT, semi-invasive,
well-tolerated,
complication of risk of
mechanical injury, but
clears rectum and can
restore normal bowel
function. Potential
limit to simulation.
Gas management
Rifaximini (non-

46
absorbed antibiotic) –
not recommend in
consideration of long
term SE of ABX,
discontinue if patients
are on during RT for
prostate.
B-galactosidase(Simethicone/pepperm
int oil) used with
caution
Diet
High fiber dieteffective at reducing
prostate motion during
RT, decrease stool,
moving gas, and
reducing rectal
volume. Patients
report increased
feeling of bloating and
flatulence.
Probiotics- reduces
radiation toxicities and
interfraction set up
errors

47
2

Bell, Cox,
Eade,
Rinks, &
Kneebone
(2014)

Nonexperiment 377 patients, Bladder preparation of
al study
Cone beam
600 mL water intake
CT
60 minutes before
simulation with
bladder volume
confirmed to be
“adequately full”
along with a low
residue diet with
magnesium to
maintain empty
rectum (rectum
>3.5cm on planning
CT resulted in patient
being given an enema
with rescan)
Rectal size had more
of an impact on
potential geographical
misses concluded its
more important to
have small rectal size
at time of simulation
and treatments> based
on findings now
routinely administer
enema before all postprostatectomy
simulations.

With this
regimen bladder
was within 1cm
of planned size
only 56.2% of
the time and
rectum within
1cm of planned
size 65.8% of
time. Of those
times when both
rectum and
bladder were
within 1cm of
planned size,
~90% of CBCT
showed no
potential
geographic miss.
A bladder 2cm
larger resulted in
61.5%
geographical
miss> based on
findings now
routinely
preform bladder
ultrasound prior
to simulation.

Used surgical clips IIIB
as surrogate for
prostate bed
motion. Small
volume of patients
(40) resulted in
sample of 377
images. 1/8 of
patients had new
plans generated
during study

48
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Braide,
QuasiKindblom, experimental
Lindencron
a, Mansson,
&
Hugosson
(2019)

29 patients,
single clinic
Sweden

Group 1 (n=13) void
and drink 300 mL of
liquid (not coffee or
tea) 60 minutes before
treatment
Group 2 (n=16)
maintain a
comfortably filled
bladder at treatment
Both groups at
simulation if rectum
was >4 cm, enema
was administered and
new CT obtained
Instructions were
given verbally and
written at time of
consult, instructions
were repeated verbally
at start of treatment
and weekly during
treatment.
Ultimately, the
variation in bladder
volume “hardly
affected the CTV” and
from a standpoint of
ensuring coverage did
not affect outcomes.

Estimated
bladder volume
median- Group
1--120 mL and
Group 2--123
mL. The intraindividual
variation in
bladder volume,
assessed as SD
for Group 1 was
64 mL (95% Cl:
(46, 105) and
Group 2 was 61
mL (95% Cl:
(45, 94), no
benefit to
drinking 300 mL
of
liquid/instructio
ns.
42% of Group 1
prepared as
instructed about
50% of the time,
approximately
31% patients in
Group 2
prepared similar

small sample size,
did not consider
development of
side-effects of RT
on ability to
maintain bladder
volume, did not
access impact of
rectum volume on
CTV

IIA
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to group 1
without
receiving
instructions.

4

Cancer
Center of
Santa
Barbara
(2017)

Expert opinion

Not
Applicable

5

DeesRibber,
Detgen,
Pos,
Witteveen,
Remeiger,
van Herk
(2014)

Quasiexperimental

24 bladder
ca patientssingle clinic
Netherlands

Empty bladder and
rectum upon arrival(15-30 minutes before
treatment) then drink
720-960 mL of water.
Refrain from eating
gas producing foods 4
hours before treatment
minimize gas- eat
slowly, chew with
mouth closed, avoid
drinking with straws,
avoid chewing gum
Drink 250 mL 60
minutes before
treatment for full
bladder

VC

bladder filling
rate of about 1.6
mL/min during
radiation
treatment

small # of patients

IIIB
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7

8

Fujioka,
Ishii,
Yamanage,
Ogino,
Kishimoto,
Kawamorit
a, …
Nakajima
(2016)
Hamilton,
McKenzie,
Wasiak, &
Fenton
(2015)

Quasiexperimental

64 Vmat
prostate
IMRT,
single center
May 2012Feb 2013

Bladder volume at
treatment planning
aim to be >100 mL
and <250 mL to
reduce nursing
intervention

Mean relative
bladder volume
of 70% for
treatment
without
exceeding dose
constrains

no daily CBCT

Quasiexperimental

10 IMRT
patients
Austria

2 groups – 5 patients
taking one capsule of
probiotics containing
1*25X10^10 units of
Lactobacillus
acidophilus NCFM
and Bifidobacterium
lactis Bi-07 a day (10x
normal dose)
5 others taking
psyllium-based bulkforming laxative
(Fyboigel tm, reckitt
benckiser, Slough,
UK; 3-5g/day
psyllium husk). >start
taking 1 packet nightly
starting 1 week prior
to simulation to
continue throughout
treatment

Probiotics
small sample size,
significantly
retrospective
increased
variation in
difference in
rectal volume
between
treatments
(p=0.0001) and
rectal cross
section area (p =
0.008) and
relative cross
section area (p =
0.007) compared
to psyllium prep.

IIB

IIA
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Bladder protocolempty bladder 30
minutes prior to
treatment, drink 500
mL of water
9

Harder, van
Gils, Kotte,
van
Vulpen, &
Lips (2014)

RTC

92 prostate
patients
IMRT 77Gy
in 35 Fx,
UMC
Utrecht

2 capsules of 250 mg
magnesium oxide
twice a day (total
100mg daily) starting
2 days before CT,
control group of
placebo capsules 2
caps/twice daily
Using MRI evaluated
for >0.5cm^3 of air as
significant amount of
gas to cause rectal
movement, occurred
in less than 1degree
and was in the
intervention group.
Does not recommend
use of mag ox
capsules daily during
treatment to reduce
rectal gas.

No significant
difference
between two
groups

Limitations listed
in original
publication

IB
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Holden,
Stanford,
D’Alimont
e, Kiss, &
Loblaw
(2014)

Quasiexperimental

Single
center, 30
patients
receiving
radical
course of
RT (78 Gy
in 38 Fx)

At time of simulation
patients were asked to
maintain a
comfortably full
bladder and then for
treatments. Patients
were preloaded with
either 250 mL or 500
mL of water, had their
bladders measured and
when bladder scanned
volume was 180 mL
preceded with
treatment.
Serum Creatinine had
no significant
correlation with the
time to achieve
bladder volume of 180
mL.
After treatment,
patients voided and
post-void residuals
were measured.

Some patients
were not able to
achieve a
bladder volume
of 180 mL, d/t
urgency or
insufficient
filling by 120
minutes. Group
1 (250 mL)
average bladder
fill to 180 mL
was 64 minutes.
Group 2 (500
mL) average
bladder fill to
180 mL was 46
minutes (p =
0.03). The time
for 95% of
patients to reach
the volume of
180 mL was 75
(group 1) and 57
minutes (group
2).

small prospective, IIB
IPSS not collected,
prostate only
radiation (no
nodes)

53
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Hosni,
Rosewall,
Craig,
Kong,
Baylaey,
Berlin, …
Chung
(2017)

Quasiexperimental

80 VMAT
79gy/39fx
group 1
diet+ Milk
of Magnesia
group 2 diet
only

Group 1 Antiflatuance
Diet + Milk of
Magnesia starting 3
days before planning
CT, continuing
through treatment.
Milk of Magnesia
initial once a day
(bedtime 30cm3,
adjusted 15-60 cm3 to
achieve a soft BM in
AM and stop with
lower GI toxicitygraded with RTOG
acuity toxicity.
Group 2 Antiflatuance
Diet only starting 3
days before planning
CT, continuing
through treatment

40% of Group 1
patients stopped
taking Milk of
Magnesia by last
week d/t
toxicity. G2
diarrhea in G1 3
patients (7.5%)
vs. 2 patients
(5%) and G1
diarrhea 21
patients (52.5%)
vs 7 patients
(17.5%), with
onset reported as
early as week 2
of treatment for
both groups.
Most
importantly, no
significant
difference in
interfraction
rectal
movement, and
therefore no
clinical impact
on accuracy of
treatment

retrospective, not
an RCA,
compliance with
diet not quantified

IIA
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delivery.
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Maggio
(2017)

Quasiexperimental

1080
prostate
3dcrt, single
site

NRBP-no rectum and
bladder preparation
protocol
RBP-protocol
preparation to empty
rectum and
comfortably full
bladder by drinking
500 mL of water 1
hour before planning
CT scan and before
each treatment fx

RBP
significantly
decreased
probability of
death from
prostate cancer,
also biochemical
and clinical
failures. Hazard
Ratio less than 1
in COX
regressions
confirm the
protective effect
of a RBP on
prostate cancer
outcome
P<0.001 mean
bladder volume
between RBP
mean bladder

retrospective, not
able to correct for
'will rogers
phenomenon'which occurs
when comparing
cohorts of cancer
patients by staging

IIA
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=305.8 +/187.8cm3 and
NRBP 125.9 +\74.5 cm3
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McGuffin,
Devji,
Kehoe,
Carty,
Russel, Di
Prospero,
…
D'Alimonte
(2019)

RTC

78 prostate
patients,
bowel and
bladder
prep, or +
80mg
simethicone
BID

Education on bowel
and bladder prep
process
empty bladder and
bowels before
drinking 500 mL of
water 30 minutes
before appointment
Intervention arm take
one 80-mg pill or
chewable
ovol(simethicone)
tablet twice per day
for 2 days before CT
simulation, 2 days
before first treatment
and then continuously
throughout the course
of treatment.
On first day of
treatment radiation
therapist provided new

The addition of
antiflatulent
medication to
the bowel prep
did not make a
clinical or
statistical
significance.
However,
overall the study
participants had
less CT rescans
then the general
population (17%
compared to
31%) which
may be in part to
the specialized
education that
was prepared to
educate patients
on bowel and

small sample size,
underpowered,
dropout after
randomization

IB
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patient teaching and
confirmed compliance
with bowel bladder
and intervention,
received daily CBCT

14

McNair,
Wedlake,
Lips,
Andreyev,
Van
Vulpen,
Dearnaley
(2014)

Systematic
Review

Not
Applicable

Oral and IV
medication- some
effectiveness with
diet, laxatives and
scheduling, no
effectiveness (adverse
effect) with Milk of
Magnesia
Diet- in studies with
just dietary advice
there was no
significant or
clinically relevant
findings with high
fiber or anti flatulent
diets
Probiotics- positive
result in rectal volume
but did lead to rectal

bladder prep;
previously the
patients were
given very little
verbal
information and
no written
information on
how to achieve
an empty rectum
and full bladder.
IIB
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MSK (n.d.)

Expert opinion

Not
Applicable

distention
Rectal Evacuationsignificant differences
in rectal volume and
corresponding prostate
motion, 1 technique
was inserting an index
finger into the rectal
canal and flushing
with water and another
used a rectal emptying
tube
Enemas- 5 studies
with enemas found
some reduction of
rectal volume of
prostate motion
Marker PlacementFiducial or beacon
transponders
Starting 7 days before
simulation take 1
rounded teaspoon of
psyllium powder in 8
oz. of water, do daily
Day of simulation do a
fleet enema 3 hours
before simulation
Use plastic mold to
help with positioning

VB
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Nathoo,
Loblaw,
Davidson,
Masunuru,
Khojaste,
& Ravi
(2018)

Quasiexperimental

Nathoo,
Loblaw,
Davidson,
Masunuru,
Khojaste, &
Ravi (2018)

17

NHS (n.d.)

Expert opinion

Not
Applicable

Void before
simulation given 500
mL of fluids to drink
over 5-10 minutes.
Ultrasound
measurements
obtained in 15-minute
intervals for up to 4
measurements before
sim. On treatment
patients voided, drank
500 mL and measured
a single time, typically
30 minutes after
voiding.

Greatest
variation
occurred in the
AP direction;
bladder volume
was on average
larger 0.5 cm
larger on
treatment. No
patients had to
get off the couch
because of
inadequate
bladder filling.
The kinetic
prediction model
Optimal bladder filling was successful
was 60 minutes after
at improving the
voiding and drinking
reproducibility
500 mL of water.
of the bladder
Adding ultrasound
volume on
increased demand on
treatment.
patient and department
resources
Drink water
(unspecified
amount) do not
advise fruit
juice, soda, tea
or coffee

Lack of
comparator data
set without the US
intervention. No
shift data info,
Treatment unit
delay coupled
impact bladder
filling on machine
result.

IIA

VC
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Oates,
RCT
Schneider,
Joon (2014)

30p, 50+ yr.,
EBRT,
intact
prostate
TNM tafge
T1- T3b.
implanted
fiducials

Standard Therapy
bladder and bowel
prep- consume 750
mL of water 30
minutes before
treatment and take
5g/d Fybogel if
needed to promote
regular bowel
movements.
Diet Interventionconsumption of
psyllium 20 g/d + at
least 2 L of water; and
antiflatulant diet
(avoid excessive dairy,
hot/spicy foods,
skins/stems of fruits
and veggies, eat
cooked veggies warm.
Reduce fat intake (can
delay the transmission
of gas). Instructions on
reducing aerophagia
(excessive and
repetitive air
swallowing i.e.
chewing gum) and
increase exercise to
increase bowel

Results show
Sample size
diet intervention
had significant
differences in
the intervention
arm for rectal
filling with a the
center with
while empty and
with gas and
feces. It suggests
that the diet
intervention may
reduce rectal
variability
compared to
standard therapy
and a larger
study should be
completed with
at least 50
enrolled in each
arm.

1B
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Osmar &
Webb
(2015)

Mixed
Methods

Odette
Cancer
Centre,
CanadaPatients and
RT staff

movements.
Empty bowel and
bladder 50 minutes
before treatment drink
750 mL water from 45
minute to 0 minutes
before treatment and
to hold bladder full
until treatment
complete. If patients
were felt to have gas,
they were encouraged
to expel the gas.
Also, avoid caffeine
for the two hours
before treatment.
Complete diet diary
for the two weeks
prior to CT simulation
until the end of
treatment.
Created a images only
picture book to help
with patient education

Staff had
comments of
success.

Patients with
limited English
proficiency were
not able to
complete the
survey.

IIIC
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Pang,
Knight,
Hussain,
Fan, Baird,
Tan, …
Tuan
(2018)

Quasiexperimental

Duel sites,
60
IMRT/VMA
T patients

Bladder protocol
empty bladder, then
drink 400-600 mL
water 30-60 min
before simulation
appointment.
Intervention TMHsame bladder protocol
+ bladder ultrasound.
No rectal empty or
dietary advice given
expect all patients
encouraged to empty
bowels before each
treatment
only 1/3 of patients
were able to obtain the
goal of >200cm3 for
simulation.
There was no
correlation between
bladder or rectal
volumes and treatment
IPSS scores. S

Bladders that
were filled to
82-113% of the
filling at
simulation
experienced
significant
Superior/inferior
(p=0.008) and
Anterior/posteri
or (p=0.0001)
movement.

Limited to short
follow up. Did not
account for
pretreatment
procedures.

IIA
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Picardi
(2015)

Quasiexperimental

20 prostate
patient, 10
with
hydrogel,
Switzerland

Bladder protocol
empty bladder, drink
600-700 mL 60
minutes before
simulation and each
treatment. Rectal
enema before
simulation and each
treatment.
Received
hypofractionations, 3
fiducial markers
10 patients received
SpaceOar hydrogel
spacer

22

Roger
Caner
Center

Expert opinion

Not
Applicable

Hydrate a few days
before hand (drink at
least 6 cups of water a
day)
Between 75- 60
minutes before
simulation/treatment,
empty bladder then
drink 600 mL water
Have BM within 4
hours of simulation
and radiation
treatment

Study confirmed single study
that the spacer
helped limit
dose to rectal
wall but failed to
prove reduction
of prostate
movement,
which would
have then
allowed for dose
escalation.

IIA

VB

63

23

Schnitzler
(2017)

Pass flatus 1 hour
before
simulation/treatment
Inform nursing staff if
you do not have daily
BM
Nonexperiment 58 pts, 10
Teachings contained
al study
RT;
medical (specialized
Australia,
words) and contextual
urban
(common words used
teaching
differently in relation
hospital; age to treatment) jargon
18+, English that was confusing for
speaking,
patients.
ineligible if
had prior RT Response include
jargon substitute,
unsolicited jargon
explanation, use of
analogies and plain
language, visual tools,
and repetition of
information. Use
empathy when
responding and refer
to Radiation
Oncologist when
unable to answer
question. Confirm
understanding with

Patients did not
remember how
many treatments
they were
scheduled for

Inconsistencies in
who information
was presented to.
Single encounter,
audio reorderings
only a small part
of the education
process, being
aware of audio
recording can lead
to bias

IIIB
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Smitsmans
(2009)

Quasiexperimental

49 prostate
cancer
patients; 23
STD, 26
Diet
intervention

Standard treatmentfull bladder by
drinking 250 mL of
liquid 60 minutes
before simulation and
treatment and empty
bowel.
Dietary interventionstandard treatment and
starting 1 week before
simulation until end of
treatment eat regularly
(no skipping meals),
drink 1.5-2 L liquid
per day, and increase
physical activity.
Avoid food: whole
wheat bread, cereals,
nuts, fermentable
carbohydrates (peas,

In dietary
intervention
group the
presence of
feces, gas
pockets, and
moving gas in
rectum was
significantly less
(p ≤0.001).
Within the DI
group there was
greater success
(p < 0.001) in
scans acquired
after 10 am;
additionally in
the standard
treatment group
the success rate

Changes in CT
imaging protocols
between the two
groups, single
study

IIA
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beans, cabbage,
onions, garlic,
peppers, asparagus),
fruits (oranges,
bananas, prunes, dried
fruits), hot and spicy
foods, carbonated
beverages, more than
>4 cups of coffee per
day; avoid swallowing
air by eat slowly and
chew food well, chew
with your mouth
closed, avoid chewing
gum, sip beverages.
Take 2 tablets of Mag
Oxide 500mg per
night starting 2 nights
before simulation, and
then 2 nights
continually through
treatment at same time
daily; treatments
scheduled after 10am.

was lower in
treatment scans
acquired before
10 am (p =0.07).

66
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Sunshine
Coast
Hospital
(2017)

Expert opinion

Not
Applicable

Fluid bladder and
empty rectum.
Hydrate with at least
1.5 L fluid (preferred
water) daily.
Take ClearLax or
Movicol daily, starting
5 days before planning
simulation.
Reduce gas formation
by: eat slowly, chew
food well with mouth
closed, avoid skipping
meals, sip fluids,
avoid straws, increase
physical activity
gently
On day of planning,
and drink 600 mL of
water 30-40 minutes
before scan.

VC
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Tsang &
Hoskin
(2017)

Quasiexperimental

60Gy/20fx
(20 patients)
IGRT; IPSS
<7, localized
prostate
cancer,
treated
between Oct
2014 and
March 2015.
Gleason
Score ≤7, no
nodes
treated.
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Uhl, van
Triest,
Eble,
Weber,
Herfarth,
De Weese

Nonexperiment Multisite,
al study
prospective,
single arm;
52 men,
prostate

Full bladder protocol,
void bowel and
bladder then 45
minutes to the start of
CT simulation drink
300 mL of water
within 15 minutes.
No bladder protocol
given for intervention
group.

Injection of hydrogel
spacer had 3-5 days
later had simulation
scan, received 78 Gy.

There was a
significant
difference in
dose objectives
due to bladder
size V42Gy (p
<0.05) and
V50Gy (p
<0.05) however
there was no
significant
difference GI
(p=1.0) and GU
(p=0.6)
toxicities; no
patients had
grade 3 or 4
toxicities.
12% of patients
experienced
grade 2 GI
toxicity. No
stage 3 or 4
toxicities
reported in acute
toxicity. In late
toxicity, only
7% of patients
reported grade 1
GI toxicity no 2,

small sample size

IIB

Single arm, small
sample sizeassessing for
stability primarily

IIIB
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Vanneste,
QuasiHoffmann, experimental
van Lin,
van de
Voorde,
Pinkawa, &
Lambin
(2016)

26 patients
(IMRT +
IRS arm)
(IMRT IRS arm)
localized
prostate
cancer,
Netherlands,
treated in
2011

10cm3 intrarectal
spacer (IRS) gel
injected into rectoprostatic space

3, or 4.
Gel was stable
during radiation
and absorbed
within 9-12
months in 42/43
patients
No significant
PTV volume
difference
between both
groups. Dose of
V75GY was
significantly
reduced to the to
the median
anorectum (p
<0.0001).
Additionally,
there was
significant
reduction in
doses to the
medical MARD,
median MRD,
and median
MAD.
Significant acute
lower GI

CI for nomograms
not incorporated
into analysis.
Nomograms only
internally
validated

IIA
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Wang, Bui,
Deville,
Plastaras,
Bar0Ad, …
Both
(2014)

Quasiexperimental

30 patients,
prostate
radiation
with CBCT,
endorectal
balloon
(ERB),
treated
12/20081/2010 at
the Hospital
of
Pennsylvani

toxicity in
between the
+IRS and -IRS
group favoring
+IRS p=,0.001,
as well as 3year
grade 2-3 lower
rectal bleeding
<0.0001 and 3
year grade 3
lower rectal
bleeding <0.002
as well as
chronic grade 23 late fecal
incontinence
0.006.
All patients received
Patient
same bowel and
comparing
bladder prep including anterior
dietary guidelines,
stool/gas
anti=gas tablets, and
volumes (<10
before planning CT
cm3) (small) to
were instructed to self- those who had
administer two Fleets
large volume
enemas, 1 hour apart.
(10-60 cm3),
larger gas
Daily, patients were
volume were
instructed to empty
twice as likely to
their rectum, and to
experience twice

bladder filling was
not measured and
can effect prostate
motion, small
sample size, single
setting, needs
more frequent
imaging

IIA
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a

consume 500 mL of
water 20-30 minutes
before treatment.
The patient was
positioned supine,
with an indexed knee
wedge, foot lock, and
lumen 100 mL waterfilled endorectal
balloon. Patients
received at least
weekly post-treatment
CBCT scans.
The study found that
100 mL water filled
balloon may not be
large enough to
immobilize the
prostate in rectums
with large gas/stool
volumes- 76% of
images showed
stool/gas volume less
than 30 mL with 90%
of total images
revealing stool/gas
volume less than 10
mL.

as much prostate
movement in the
6th minute of
treatment.

71
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Weston,
Luscombe,
&
Duncanson
(2019)

RTC

31

Yaver, Foo, QuasiLarsen,
experimental
Fineberg,
Zeng,
McGowan,
& Jones
(2015)

CBCT scans
17 patients
prostate
radiation, 612/2016,
single center
Australia,
receiving
EBRT 78
Gy in 39 Fx

Ontario
cancer
center. 59
prostate
cancer
radiotherapy
patients

Intervention groupbulking laxative
(Metamucil equivalent
of 10 g soluble fiber
per day) with probiotic
Standard treatmentosmotic laxative
(Movicol half
strength, Macrogol
3350 6.563 g)
both low gas diet (low
in fermentable carbs,
gastric irritants, and
carbonated beverages)
provided by dietitian
prior to radiation
therapy planning
appointment and
weekly throughout
treatment, gold
fiducial markers
Cohort 1- (Laxative) fleets enema the
morning of simulation
planning, Milk of
Magnesia daily during
treatments
Cohort 2 (consistent
timing) - appointment
times aligned with

Osmotic laxative
was significantly
more effective
(p<0.001) at
reducing rectal
gas volume

subjective analysis
of gas levels,
limited external
validity, probiotic
only in IG group

IB

There was no
difference
between the two
cohorts in gas
volume, rectal
volume, bladder
volume in PTV,
rectal volume in
PTV, and target

Interobserver
IIA
variability on
CBCT, exclusion
of dose analysis,
toxicity outcomes,
and patient
reported
outcomes/difficulti
es with

72
natural bowel habits,
time collected during
prescreening intact
appointment.
Additionally, those
patients with no
preexisting urinary
conditions were
instructed to drink 2L
water daily before
simulation and during
treatment
All patients instructed
to drink 250 mL water
60 minutes before
planning and daily
appoints.

coverage.
Patients should
be offered a
choice.
The bladder
regimen for
cohort 2 was
superior for
consistency with
slightly larger
maintained
bladder volume
over the
duration of
treatment.

maintaining
regimens
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Appendix B: Interventions to Prepare a Patient With Prostate Cancer for External Beam
Radiation Therapy
Introduction
The intent of this clinical practice guideline is to provide guidance for radiation
oncology healthcare to choose more appropriate and achievable interventions (Institute of
Medicine, 2011). Specifically, this guideline will aim to help improve the planning
session for prostate radiation therapy as it relates to modifiable factors such as bladder
management, bowel management, and image quality. Patients that are the target
population of this CPG are males, with localized prostate cancer, planned to receive
intensity modulated radiation therapy (IMRT). Providers may consider these guidelines
for other radiation treatments such as hypofractionated treatment and proton radiation
however, the sources of evidence were primarily IMRT studies and that consideration
should be made when applying the CPG outside of this population. Patients who prior to
starting radiation therapy have challenges with bowel management or known dietary/fluid
restrictions may need to be recommended a modified version of the clinical practice
guideline and healthcare providers should consider consulting a nutritionist for
assistance.
Formulating the recommendations
A literature review was conducted using CINAHL Plus with Full Text, MEDLINE
with Full Text, PubMed, Ovid Nursing, Embase, ProQuest Nursing and Allied Health
Source, and Google Scholar. The following terms were used in the literature search:
prostate, prostate cancer, radiation therapy, radiotherapy, simulation, bladder filling,
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bladder regimen, bladder protocol, bowel emptying, bowel regimen, bowel protocol,
fiducials, prostate motion, clinical practice guideline, AGREE II, implanted rectal
spacer, and hydrogel. Additionally, the Boolean strings and/or were used to obtain a
more comprehensive search. Abstracts were reviewed to identify articles that best
appeared to match the practice question, 62 articles were identified. Publication years
were limited to 2014-2019 initially, an additional search to update any articles that added
providers (MDs, advanced care practitioners, registered nurses, radiation therapists) to
prepare patients with prostate cancer for radiation therapy planning session and treatment.
The expected benefit of having clinical practice guidelines improve equity of care, reduce
variations in care, assist in social change, and aim to define best practices in healthcare.
CPGs allow the provider to identify barriers and thus choose more appropriate and
achievable interventions.
The initial literature review had publication years limited to 2014-2019 initially, so an
additional search in the summer of 2020 was conducted to ensure all up to date articles
were included; historical research were identified through the citation chaining methods.
Sources of evidence were not be limited to those published in the US so spelling variation
was included to account for international studies. A final 31 sources of evidence were
used to inform the CPG.
After evidence is acquired through the literature review, it is evaluated for level and
quality using the Johns Hopkins Nursing Evidence Based Practice (JHNEBP) model. The
JHNEBP is used to evaluate the level and quality of each evidence source, then
summarize the evidence, and synthesize the collective evidence for quality and strength
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(Dearholt & Dang, 2012). In the JHNEBP model evidence is leveled based on the source
or evidence ranging from I-V including both research and non-research forms of
evidence, then the evidence is rated based on quality; evidence may receive a score of A
for high quality, B for good quality, and C for low quality or major flaws within the
evidence. Based on the JHNEBP evidence from all types of sources can be considered,
this allows for includes of internal and external forces when considering the application
of identified best practices which is helpful in the development of a practical CPG. The
evidence selected that informed this CPG was based on the reported outcomes, quality,
level, frequency, ability to implement, and patient tolerability.
Clinical Practice Guideline Recommendations
Primary recommendations
Category

Recommendation

Bladder
Management

Empty bladder then drink 500 mL of water
finishing 6o minutes before simulation/treatment
Goal bladder volume via ultra sound of >100 mL
and <250 mL at the time of simulation
Consume at least 1.5L- 2L water daily
Patient should have an empty rectum for treatment,
to do this they should strive to have a bowel
movement daily before treatment and should pass
flatulence 1-2 hours before treatment.
Gas Management (Diet)Provide education and recommend an antiflatulance
diet: avoid fermentable carbohydrates including
lentils, beans, peas, broccoli, cauliflower, Brussel
sprouts, cabbage, sauerkraut, cucumber, turnip,
onions, garlic, apples, bananas, carbonated
beverages, dairy, high-fat foods.
Gas Management (Eating Style) - Reduce
aerophagia (excessive and repetitive air
swallowing). Do this by eating with mouth closed,

Bowel Management

Highest
Level of
Evidence
IIA
IIB
IB
IIA

IIA

IB
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eat slowly, and chew food well. Do not use chewing
gum, avoid using straws if able, and sip beverages.
Recommend osmolotic laxative, nightly starting 5
days before simulation and continue through
treatment, reduce as need for excessive stools.
Recommend Fleet® enema if unsuccessful with
other interventions and/or rectum is greater than
>3.5 cm on simulation CT.
Recommend increase exercise to promote bowel
motility.
Imaging/Treatment
Give patients consistent appointment times that
Quality
align with their daily bowel habits.
Interstitial biodegradable balloons (hydrogel
spacers) should be injected at least 3-5 days before
simulation.
Patient Education
Provide verbal and written specialized patient
education.
Add images to patient education.
Use analogies, plain language, repeat information.
Refer to radiation oncologist when unable to answer
a patient’s direct question. Confirm patient’s
understanding with the use of teach back method.
Secondary recommendations

IB

IIIB

IB
IIA
IIA

IB
IIIB
IIIB

Magnesium-several studies found no benefit of the addition of magnesium (Milk
of magnesium or magnesium tablets) for bowel management on a routine basis.
One study found that most patients stopped taking routine Milk of Magnesium
due to GI toxicity before the end of treatment.



Rectal emptying tube is not recommended related to possible incorrect
placement and invasive nature, as well as repeated need for each treatment.



Rectal balloon- patients that receive rectal balloons instead of interstitial
biodegradable balloons may need >100cc volume instilled if they experience
larger rectal gas volumes to reduce prostate motion.
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Probiotics- daily probiotics had conflicting evidence and no recommendations
can be made without further studies on the impact of daily probiotics on prostate
radiation side effects or bowel management for prostate radiation.



Gas managemento Rifaximini, a non-absorbed antibiotic, is not advised for use during
radiation treatment of prostate cancer and should be discontinued if
patients are one prior to treatment.
o Simethicone/peppermint oil, should be used with caution and were not
shown to have statistical or clinical significance when added as
preventative management for gas management.
Strengths within the body of evidence include obtaining patient feedback on

interventions were taken into consideration when developing the recommendations, the
large number of sources of evidence often addressed several aspects areas within the
recommendations allowing for multilayered support of the recommendations put forward.
The limitations within the body of evidence include inconsistent definitions between
studies, studies having small sample sizes, lacking control, and limited randomized
control trials. Additional limitations include advancements of, and variations in, radiation
therapy administration between the bodies of evidence, which had potential impact on the
patient experience during the studies that informed the evidence.

